Association Between Cerebral Patterns of Fibrillar Beta-Amyloid Burden and Glucose Hypometabolism in Cognitively Normal Older Adults at Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease

Adam S. Fleisher,Kewei Chen,Xiaofen Liu,Napatkamon Ayutyanont,Jessica B.S. Langbaum,Wendy Lee,Stephanie A. Reeder,Gene E. Alexander,Dan Bandy,Richard J. Caselli,Eric M. Reiman

DOI: https://doi.org/10.1016/j.jalz.2010.05.011

2010-01-01

Abstract:We previously found that apolipoprotein E (APOE) ∊4 gene dose, reflecting three levels of genetic risk for late-onset Alzheimer's disease (AD), is associated with characteristic patterns of glucose hypometabolism and fibrillar amyloid-beta (Aβ) burden in cognitively normal older adults (Reiman et al, 2004; 2009). We have also introduced an automated algorithm, known as multi-modal partial least squares (MMPLS), to characterize the linkage between patterns in two or more complementary complex data sets from the same person on a voxel-by-voxel basis (Chen et al, 2009). In this study, we used MMPLS to characterize how APOE ∊4 gene dose is associated with patterns of cerebral hypometabolism and fibrillar Aβ burden. We investigated how metabolic and Aβ measurements, in respective clusters of preferentially affected voxels, are related to each other. MMPLS was used in “informed mode” for the simultaneous analysis of fluorodeoxyglucose (FDG) and Pittsburgh Compound B (PiB) positron emission tomography (PET) images from 11 ∊4 homozygotes, 11 ∊4 heterozygotes, and 16 ∊4 noncarriers who were cognitive normal (65 ± 5 years old). Patterns of cerebral-to-whole brain FDG PET counts and cerebral-to-cerebellar PiB Distribution Volume Ratios (DVRs) most closely associated with APOE ∊4 gene dose were characterized. ∊4 homozygote, heterozygote, and non-carrier groups did not differ significantly in their age, gender distribution, educational level, Mini-Mental State Examination scores (29.6 ± 0.8), or Auditory Verbal Learning Test long-term memory scores. Patterns most closely associated with APOE ∊4 gene dose were notable for lower glucose metabolism in the precuneus and posterior cingulate cortex and increased fibrillar Aβ in the precuneus, posterior cingulate cortex and medial prefrontal cortex. As expected, there was a strong correlation between lower cerebral glucose metabolism and higher fibrillar Aβ in respective empirically defined statistical regions-of-interest (comprised of voxels associated with ∊4 gene dose at p≤0.005) in all 38 subjects (r = -0.46, p = 0.0039) and in the 22 ∊4 carriers (r = -0.47, p = 0.028). Larger sample sizes are needed to further characterize the relationships for each APOE genotype. There is a strong relationship between the pattern of regional hypometabolism and fibrillar Aβ deposition associated with three levels of genetic risk for late-onset AD in cognitively normal adults.